Supervisory Board

Dr. Cillian King is an Investment Manager at Swanbridge Capital and founding-investor of Pan Cancer T. He joined the Board of Pan Cancer T in September 2020. Mr. King serves on the Board of Allero Therapeutics.

Prior to Swanbridge Capital he worked as a consultant for early-stage ventures in the life sciences industry.

Mr. King has a background in Molecular Biology (VU University and MIT) and a PhD in Molecular Neuroscience (VU University).

Mr. Robert Overdijk is the director of the Erasmus MC Holding in Rotterdam. The Holding offers an organizational framework for 32 legal health care related entities with a link to Erasmus MC.

Mr. Overdijk has over 20 years of management experience in health care. Rob is a member of the supervisory board of several profit and non-profit organizations.

Mr. Overdijk obtained a master degree in business economics at the Erasmus University in Rotterdam.